Pharmacokinetics and placental transfer of elvitegravir, dolutegravir, and other antiretrovirals during pregnancy
BH Rimawi, E Johnson, A Rajakumar… - Antimicrobial agents …, 2017 - Am Soc Microbiol
The integrase inhibitors elvitegravir (EVG) and dolutegravir (DTG) rapidly decrease the
plasma HIV-1 viral load, a key factor in the prevention of maternal-to-fetal transmission of …
plasma HIV-1 viral load, a key factor in the prevention of maternal-to-fetal transmission of …
[PDF][PDF] Pharmacokinetics and placental transfer of elvitegravir, dolutegravir, and other antiretrovirals during pregnancy
BH Rimawi, E Johnson, A Rajakumar… - Antimicrob Agents …, 2017 - researchgate.net
The integrase inhibitors elvitegravir (EVG) and dolutegravir (DTG) rapidly decrease the
plasma HIV-1 viral load, a key factor in the prevention of maternal-tofetal transmission of HIV …
plasma HIV-1 viral load, a key factor in the prevention of maternal-tofetal transmission of HIV …
Pharmacokinetics and Placental Transfer of Elvitegravir, Dolutegravir, and Other Antiretrovirals during Pregnancy.
BH Rimawi, E Johnson, A Rajakumar… - Antimicrobial Agents …, 2017 - europepmc.org
The integrase inhibitors elvitegravir (EVG) and dolutegravir (DTG) rapidly decrease the
plasma HIV-1 viral load, a key factor in the prevention of maternal-to-fetal transmission of …
plasma HIV-1 viral load, a key factor in the prevention of maternal-to-fetal transmission of …
[HTML][HTML] Pharmacokinetics and Placental Transfer of Elvitegravir, Dolutegravir, and Other Antiretrovirals during Pregnancy
BH Rimawi, E Johnson, A Rajakumar… - Antimicrobial Agents …, 2017 - ncbi.nlm.nih.gov
The integrase inhibitors elvitegravir (EVG) and dolutegravir (DTG) rapidly decrease the
plasma HIV-1 viral load, a key factor in the prevention of maternal-to-fetal transmission of …
plasma HIV-1 viral load, a key factor in the prevention of maternal-to-fetal transmission of …
Pharmacokinetics and Placental Transfer of Elvitegravir, Dolutegravir, and Other Antiretrovirals during Pregnancy
BH Rimawi, E Johnson… - Antimicrobial …, 2017 - pubmed.ncbi.nlm.nih.gov
The integrase inhibitors elvitegravir (EVG) and dolutegravir (DTG) rapidly decrease the
plasma HIV-1 viral load, a key factor in the prevention of maternal-to-fetal transmission of …
plasma HIV-1 viral load, a key factor in the prevention of maternal-to-fetal transmission of …
Pharmacokinetics and placental transfer of elvitegravir, dolutegravir, and other antiretrovirals during pregnancy.
BH Rimawi, E Johnson, A Rajakumar, TSJ Tao SiJia… - 2017 - cabidigitallibrary.org
The integrase inhibitors elvitegravir (EVG) and dolutegravir (DTG) rapidly decrease the
plasma HIV-1 viral load, a key factor in the prevention of maternal-to-fetal transmission of …
plasma HIV-1 viral load, a key factor in the prevention of maternal-to-fetal transmission of …
Pharmacokinetics and Placental Transfer of Elvitegravir, Dolutegravir, and Other Antiretrovirals during Pregnancy.
BH Rimawi, E Johnson, A Rajakumar… - Antimicrobial Agents …, 2017 - europepmc.org
The integrase inhibitors elvitegravir (EVG) and dolutegravir (DTG) rapidly decrease the
plasma HIV-1 viral load, a key factor in the prevention of maternal-to-fetal transmission of …
plasma HIV-1 viral load, a key factor in the prevention of maternal-to-fetal transmission of …